Skip to main content

Arthroscopy

2
Pipeline Programs
4
Companies
3
Clinical Trials
1
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
2
Early DiscoveryClinical DevelopmentMarket

Drug Modality Breakdown

Small Molecule
1100%
+ 2 programs with unclassified modality

On Market (1)

Approved therapies currently available

Viatris
CELEBREXApproved
celecoxib
Viatris
Nonsteroidal Anti-inflammatory Drug [EPC]oral1998
16M Part D

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Viatris
ViatrisCANONSBURG, PA
1 program
1
CelecoxibPhase 4Small Molecule1 trial
Active Trials
NCT00633386Completed200Est. Aug 2003
Fresenius Kabi
Fresenius KabiGermany - Bad Homburg
1 program
Effects of Shoulder Edema on Intubated Tube in Patients Undergoing Shoulder ArthroscopyN/A1 trial
Active Trials
NCT02184702Completed40Est. Jul 2016
Eisai
EisaiChina - Liaoning
1 program
fospropofol disodiumPHASE_31 trial
Active Trials
NCT00209560Terminated168Est. Mar 2005

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
ViatrisCelecoxib
Eisaifospropofol disodium
Fresenius KabiEffects of Shoulder Edema on Intubated Tube in Patients Undergoing Shoulder Arthroscopy

Clinical Trials (3)

Total enrollment: 408 patients across 3 trials

NCT00633386ViatrisCelecoxib

Effect of Celecoxib Versus Placebo Before and After Knee Surgery on the Overall Use of Analgesics After Surgery

Start: Feb 2003Est. completion: Aug 2003200 patients
Phase 4Completed
NCT00209560Eisaifospropofol disodium

A Study of AQUAVAN® Injection in the Presence of Pre-Medication in Patients Undergoing Minor Surgical Procedures

Start: Oct 2004Est. completion: Mar 2005168 patients
Phase 3Terminated
NCT02184702Fresenius KabiEffects of Shoulder Edema on Intubated Tube in Patients Undergoing Shoulder Arthroscopy

Effects of Shoulder Edema on Intubated Tube in Patients Undergoing Shoulder Arthroscopy

Start: Jun 2014Est. completion: Jul 201640 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

4 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.